EMA’s human medicines committee (CHMP) has recommended authorising two vaccines adapted to provide broader protection against COVID-19. Comirnaty Original/Omicron BA.1 and Spikevax Bivalent Original/Omicron BA.1 are for use in people aged 12 years and above who have received at least primary vaccination against COVID-19. These vaccines are adapted versions of the original vaccines Comirnaty (Pfizer/BioNTech) […]
Read More
Commission decides to register new European Citizens’ Initiative on tobacco
The Commission decided to register a European Citizens’ Initiative (ECI) entitled ‘Call to achieve a tobacco-free environment and the first European tobacco-free generation by 2030′. The organisers of the initiative call on the Commission to propose legislation to save new generations from falling into tobacco addiction, to act against related environmental dangers and against smoking. […]
Read More
EMA advises on intradermal use of Imvanex / Jynneos against monkeypox
The European Medicines Agency (EMA) has advised on intradermal use of monkeypox vaccine. EMA’s Emergency Task Force (ETF) has reviewed data showing that people who receive the monkeypox vaccine as an intradermal injection (injection into the skin) produce similar levels of antibodies to those who receive it as a subcutaneous injection (injection under the skin). As only […]
Read More
Coronavirus Present Situation in Africa
This news item shows updated data, obtained from various official sources (Johns Hopkins University, Reuters, WHO…), on the incidence of diagnosed cases and deaths due to the COVID-19 virus in Africa. Countries with the highest average incidence of cases diagnosed in the last 7 days Looking at the data as of August 19, 2022, […]
Read More
COVID-19 vaccines: Commission and Moderna delivery schedules
The European Commission and Moderna have reached an agreement to better address Member States needs for COVID-19 vaccines for the late summer and winter period. This will ensure national authorities have access to the vaccines, including variant-adapted vaccines if authorised, at the time they need them for their own vaccination campaigns and to support their […]
Read More
Joint Procurement contract HIPRA for Covid-19
HERA, the European Commission’s Health Preparedness and Response Authority, has signed a joint procurement Framework Contract with the company HIPRA HUMAN HEALTH for the supply of their protein COVID-19 vaccine. 14 Member States and countries are participating in this joint procurement, under which they can purchase up to 250 million doses. As the number of cases is […]
Read More
HERA signs Joint Procurement contract for Pandemic Influenza Vaccine
Today, the European Commission, via its Health Emergency Preparedness and Response Authority, signed a framework contract for the joint procurement of Adjupanrix, a pandemic influenza vaccine, with the pharmaceutical company GSK. 12 Member States and other joint procurement countries are participating in the agreement, under which they can purchase up to 85,000,000 vaccine doses if necessary, in the […]
Read More
ECDC to participate in a pilot project for the European Health Data Space: towards new opportunities for health research in Europe
The European Commission recently announced its decision to choose a consortium led by the French Health Data Hub to set up a pilot project for the European Health Data Space (EHDS). This project will aim to feed the legislative discussions around the draft regulation proposed by the European Commission on May 3rd on the European Health […]
Read More
EU and World Vision’s COVID-19 response programme enhance resilience and livelihoods of vulnerable communities in Indonesia
The European Union (EU), World Vision Netherlands and Wahana Visi Indonesia held a closing ceremony of their two-year project “Indonesia COVID-19 Pandemic Emergency Responses (I-COPE)”. The project has contributed to limiting the spread of COVID-19 and reducing its impact on vulnerable children and families in Indonesia. The project is implemented in 90 villages in six districts/ […]
Read More